Lewes, DE -- (SBWIRE) -- 10/14/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: HEMP, INC. (OTCMKTS:HEMP), Soligenix Inc (OTCBB:SNGX), PV ENTERPRISES (OTCMKTS:VDSC) CytoDyn Inc (OTCMKTS:CYDY).
HEMP, INC. (OTCMKTS:HEMP) opened its last trade at the price of $0.02. Its closing price was $0.0179 after losing -0.56% for the day. The company traded with the total volume of 2.22 million shares, while its average trading volume remained 12.74 million shares. The beta of this stock stands at 1.23. Hemp, Inc. focuses on supplying services, products, and information related to the medical marijuana industry or to those who have an affinity for the medical marijuana industry.
Will HEMP Get Buyers Even After The Recent Rally? Find Out Here
Soligenix Inc (OTCBB:SNGX) percentage change plunged -5.05% to close at $1.88 with the total traded volume of 93.964 shares while its average volume of 96.332 shares. The 52 week range of the stock remained $0.43 - $2.48, while its day lowest price was $1.80. The share price hit the day highest price of $1.99. Soligenix, Inc., a development stage biopharmaceutical company, engages in developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents.
Will SNGX Get Buyers Even After The Recent Rally? Find Out Here
PV ENTERPRISES (OTCMKTS:VDSC) traded on volume of 23.54 million shares in the last session against average volume of 46.88 million shares. The company closed at $0.0016 and showed no change. In the last three months the stock was down -75.38%. PV Enterprises International Inc. operates as a regional cruise and charter holding company. It is involved in cruise ship and ferry operations.
Is VDSC a Solid Investment at These Levels? Find Out Here
CytoDyn Inc (OTCMKTS:CYDY) started its last trading session with the price of $1.10 and closed at $1.35 by scoring 22.73 The stock traded with total volume of 97.587 shares, while the average trading volume remained 20.246 shares. The beta value of this stock stands at 1.89. Day range for the stock was $1.10 and $1.42. CytoDyn Inc., a development stage biotechnology company, focuses on the discovery and development of therapeutic monoclonal antibodies to treat human immunodeficiency virus (HIV) infection.
Will CYDY Continue To Move Higher? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/